New York, NY -- (SBWIRE) -- 01/09/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: New York Mortgage Trust, Inc (NASDAQ:NYMT), Fusion-IO, Inc (NYSE:FIO), XOMA Corp (NASDAQ:XOMA), Tower Group International, Ltd (NASDAQ:TWGP)
New York Mortgage Trust, Inc (NASDAQ:NYMT) showed a volume of 2.32 million shares by the end of last trade whereas the average volume of the stock 1.34 million shares. The stock opened the session at $6.79 but then moved to $6.83. At that price, the stock showed a positive performance of 0.59%. New York Mortgage Trust, Inc. (NYMT), together with its consolidated subsidiaries, is a self-advised real estate investment trust (REIT). The Company is engaged in acquiring and managing primarily residential adjustable-rate, hybrid adjustable-rate and fixed-rate mortgage-backed securities (RMBS), for which the principal and interest payments are guaranteed by a United States Government agency, such as the Government National Mortgage Association (Ginnie Mae), or a United States Government-sponsored entity (GSE or Agency),
Will NYMT Continue To Move Higher? Find Out Here
Fusion-IO, Inc (NYSE:FIO) opened the session at $9.05 and closed the session at $8.92. The stock showed a negative performance of -1.33% in previous trading session. Fusion-io Inc (Fusion) is a provider of datacenter solutions that accelerate databases, virtualization, cloud computing, big data, and the applications that help drive business from the smallest e-tailers to some of the largest data centers, social media leaders, and Fortune Global 500 businesses. The Company's integrated hardware and software platform enables the decentralization of data from legacy architectures and specialized hardware. The Company sells its solutions through a global direct sales force,
Has FIO Found The Bottom And Ready To Gain Momentum? Find Out Here
XOMA Corp (NASDAQ:XOMA) opened the session at $6.39 and closed the session at $7.16. The stock showed a positive performance of 2.29% in previous trading session. The beta of the stock remained 2.41. XOMA Corporation (XOMA) is engaged in the discovery and development of antibody-based therapeutics. The Company’s lead drug candidate is gevokizumab (formerly XOMA 052), a humanized monoclonal allosteric modulating antibody designed to inhibit the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta). The Company’s preclinical pipeline includes classes of antibodies that activate or sensitize the insulin receptor in vivo, named XMet, and represent potential new therapeutic approaches to the treatment of diabetes and several diseases that have insulin involvement.
Why Should Investors Buy XOMA After The Recent Gain? Just Go Here and Find Out
Tower Group International, Ltd (NASDAQ:TWGP) the stock decreased -2.05% and finished the session at $2.87. Traded with volume of 2.24 million shares in the prior session and the average volume of the stock remained 3.60 million shares. The beta of the stock remained 0.71.
Will TWGP Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)